C07K 16/2863
Against receptors for growth factors, growth regulators
Official title: {against receptors for growth factors, growth regulators}
C07K16/2863 (Against receptors for growth factors, growth regulators) appears on 3,023 US grants and 5,939 published applications in this corpus.
Search patents in C07K- Granted patents
- 3,023
- Published applications
- 5,939
- Assignees
- 1,607
- Inventors
- 9,073
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 7 | 0 |
| 1996 | 6 | 0 |
| 1997 | 13 | 0 |
| 1998 | 27 | 0 |
| 1999 | 32 | 0 |
| 2000 | 15 | 0 |
| 2001 | 21 | 6 |
| 2002 | 23 | 39 |
| 2003 | 11 | 42 |
| 2004 | 10 | 52 |
| 2005 | 10 | 72 |
| 2006 | 29 | 77 |
| 2007 | 17 | 94 |
| 2008 | 30 | 98 |
| 2009 | 55 | 146 |
| 2010 | 62 | 177 |
| 2011 | 58 | 178 |
| 2012 | 82 | 181 |
| 2013 | 95 | 241 |
| 2014 | 128 | 321 |
| 2015 | 147 | 314 |
| 2016 | 202 | 341 |
| 2017 | 199 | 402 |
| 2018 | 209 | 327 |
| 2019 | 242 | 332 |
| 2020 | 199 | 341 |
| 2021 | 206 | 392 |
| 2022 | 182 | 355 |
| 2023 | 183 | 359 |
| 2024 | 198 | 440 |
| 2025 | 182 | 339 |
| 2026 | 135 | 273 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibody recognizing extracellular region of ALK2/ACVR16 Oct 2026US 12,753,237 B2Saitama Medical University
- Agonist antibodies against endoglin and uses thereof6 Oct 2026US 12,753,238 B2The Feinstein Institutes for Medical Research
- Bifunctional molecules for lysosomal targeting and related compositions and methods6 Oct 2026US 12,753,239 B2The Board of Trustees of the Leland Stanford Junior University
- Anti-ABCG2 antibodies and uses thereof6 Oct 2026US 12,753,241 B2William Robert Arathoon Living Trust Dated August 29, 2016
- RNA encoding an antibody29 Sep 2026US 12,747,451 B2Cure Vac SE
- Anti-cmet antibody, antibody-drug conjugate, and preparation method therefor and use thereof8 Oct 2026US 2026/0306651 A1MediLink Therapeutics (Suzhou) Co., Ltd.
- Radiolabeled met binding proteins for immuno-pet imaging8 Oct 2026US 2026/0306682 A1Regeneron Pharmaceuticals, Inc.
- Multi-receptor natural killer cells8 Oct 2026US 2026/0308225 A1Board of Regents, The University of Texas System
- Cd3 binding molecules8 Oct 2026US 2026/0308254 A1Merus N.V.
- Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof8 Oct 2026US 2026/0308274 A1Genentech, Inc.
Most cited
By later US patents
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Methods for producing members of specific binding pairs849US 5,733,743 ACambridge Antibody Technology Limited · 1998
- Production of anti-self antibodies from antibody segment repertoires and displayed on phage541US 5,885,793 ACambridge Antibody Technology Limited · 1999
- Optimized Fc variants463US 7,317,091 B2Xencor, Inc. · 2008
- Human monoclonal antibodies to epidermal growth factor receptor367US 6,235,883 B1Abgenix, Inc. · 2001